Engineering next-generation platforms to unlock the potential of cell-based therapies in treating human diseases
The research at the Bose Lab lies at the interface of biomaterial science, cellular engineering, and drug delivery with the aim of creating next-generation cell-based therapies for a wide range of human diseases. The lab combines multiscale device fabrication, material chemistry, and cell engineering principles to develop platform technologies capable of delivering precise doses of drugs (biologics) at the right location in the body at the right time. These platforms have applications in treating chronic diseases such as diabetes and liver failure, immune engineering applications in cancer and autoimmunity, and regenerative medicine.
“The Bose laboratory combines multiscale device fabrication, material chemistry, and molecular and cell engineering principles to gain insights into fundamentals of cellular interactions and apply these discoveries to design effective cell-based therapies”
News
-
![]()
MIRA Award
8/1/24: Bose lab receives an R35 MIRA Award from NIGMS for developing new therapeutic cells and delivery devices.
-
![]()
-
![]()
Mayo Core Grant
6/15/24: Our lab receives the Mayo Clinic Core Grant, which provides $25K in funding for using Mayo Clinic Core Facilities to pursue high-impact ideas.
-
![]()
In vivo O2 generating implants
-
![]()
Peter Karches Mentorship Prize
-
![]()
Cell encpasulation devices
-
![]()
Koch Image Award
-
![]()
K99/R00 Award from NIBIB
6/1/2018: Dr. Bose wins K99/R00 Pathway to Independence award from NIBIB to develop single cell microRNA technology.
-
![]()
-
![]()
-
![]()
